| Bid Price | 5.00p | High Price | 5.60p |
|---|
| Ask Price | 5.50p | Low Price | 4.80p |
|---|
| Open Price | 5.60p | Spread | 9.09% |
|---|
| Prev Close | 5.60p | Volume | 3,466,060 |
|---|
Roquefort Therapeutics PLC Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Nov 1, 2024 | 5.60 | 5.60 | 4.80 | 5.25 | 3,466,060 |
| Oct 31, 2024 | 4.85 | 6.00 | 4.80 | 5.60 | 6,494,679 |
| Oct 30, 2024 | 4.25 | 4.92 | 4.26 | 4.85 | 1,508,893 |
| Oct 29, 2024 | 4.45 | 4.40 | 4.15 | 4.25 | 629,706 |
| Oct 28, 2024 | 3.95 | 4.54 | 4.00 | 4.45 | 2,020,376 |
Roquefort Therapeutics PLC Information
| Name | Roquefort Therapeutics PLC | Index | |
|---|
| ISIN | GB00BMDQ2T15 | Epic | ROQ |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | SSQ3 |
|---|
| Industry | Biotechnology | Sector | Healthcare |
|---|
| EMS | 20,000 | Trading Status | Closed |
|---|
| Shares in Issue | 129.15 m | Prev Close | 5.60p |
|---|
| PE Ratio | | Market Cap | £6.78 m |
|---|
| Div Yield | 0 | Div per Share | £NaN |
|---|
| EPS | £-0.00 | Div Cover | NaN |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | -0.097595 | DPS Growth (%) | 0 |
|---|
| Current Ratio | 0.791677 | Quick Ratio | 0.791677 |
|---|
Roquefort Therapeutics PLC Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 02/08/23 | BUY | Darrin Disley | NED | 269,935 @ £0.07 | £19,840.00 |
| 12/07/23 | BUY | Stephen West | CH | 15,730 @ £0.06 | £983.00 |
| 12/07/23 | BUY | Stephen West | CH | 143,390 @ £0.06 | £8,948.00 |
| 26/06/23 | BUY | Stephen West | CH | 144,117 @ £0.07 | £9,944.00 |
| 26/06/23 | BUY | Simon Sinclair | NED | 35,921 @ £0.07 | £2,489.00 |
| 26/06/23 | BUY | Trevor Reginald | CEO | 1,350 @ £0.07 | £93.00 |
| 26/06/23 | BUY | Trevor Reginald | CEO | 2,600 @ £0.07 | £184.00 |
| 26/06/23 | BUY | Trevor Reginald | CEO | 2,600 @ £0.07 | £180.00 |
| 26/06/23 | BUY | Trevor Reginald | CEO | 28,715 @ £0.07 | £2,033.00 |
| 28/09/22 | BUY | Stephen West | CH | 62,040 @ £0.08 | £4,963.00 |
Roquefort Therapeutics PLC News
